Santilli F et al. |
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. |
2006 |
J. Am. Coll. Cardiol. |
pmid:16412866
|
Cuiper LL et al. |
Systemic and pulmonary hypertension after abrupt cessation of prostacyclin: role of thromboxane A2. |
1996 |
J. Appl. Physiol. |
pmid:8847301
|
Gremmel T et al. |
Differential impact of inflammation on six laboratory assays measuring residual arachidonic acid-inducible platelet reactivity during dual antiplatelet therapy. |
2013 |
J. Atheroscler. Thromb. |
pmid:23739624
|
Yi X et al. |
Platelet response to aspirin in Chinese stroke patients is independent of genetic polymorphisms of COX-1 C50T and COX-2 G765C. |
2013 |
J. Atheroscler. Thromb. |
pmid:22972377
|
Böhm E et al. |
11-Dehydro-thromboxane B2, a stable thromboxane metabolite, is a full agonist of chemoattractant receptor-homologous molecule expressed on TH2 cells (CRTH2) in human eosinophils and basophils. |
2004 |
J. Biol. Chem. |
pmid:14668348
|
Vazzana N et al. |
Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress. |
2012 |
J. Clin. Endocrinol. Metab. |
pmid:22761461
|
Cesari M et al. |
Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study. |
2012 |
J. Gerontol. A Biol. Sci. Med. Sci. |
pmid:22389462
|
Laffi G et al. |
Defective aggregation in cirrhosis is independent of in vivo platelet activation. |
1996 |
J. Hepatol. |
pmid:8738730
|
Foegh ML et al. |
Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain. |
1994 |
J. Intern. Med. |
pmid:8308478
|
Morrow JD et al. |
Increased formation of thromboxane in vivo in humans with mastocytosis. |
1999 |
J. Invest. Dermatol. |
pmid:10417625
|